Kenneth Hoberman
2015
In 2015, Kenneth Hoberman earned a total compensation of $1.8M as Chief Operating Officer at Stemline Therapeutics, which was about the same as previous year.
Compensation breakdown
| Bonus | $205,448 |
|---|---|
| Option Awards | $768,029 |
| Salary | $414,000 |
| Stock Awards | $383,969 |
| Total | $1,771,446 |
Hoberman received $768K in option awards, accounting for 43% of the total pay in 2015.
Hoberman also received $205.4K in bonus, $414K in salary and $384K in stock awards.
Rankings
In 2015, Kenneth Hoberman's compensation ranked 5,231st out of 13,638 executives tracked by ExecPay. In other words, Hoberman earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,231 out of 13,638 | 62nd |
Division Manufacturing | 1,934 out of 5,190 | 63rd |
Major group Chemicals And Allied Products | 703 out of 1,854 | 62nd |
Industry group Drugs | 558 out of 1,528 | 64th |
Industry Pharmaceutical Preparations | 438 out of 1,182 | 63rd |
Source: SEC filing on May 1, 2017.
Hoberman's colleagues
We found three more compensation records of executives who worked with Kenneth Hoberman at Stemline Therapeutics in 2015.